2022 World Conference on Lung Cancer (ePosters)-EP02.03-006. Oncological Outcome And Surgical Instruments in VATS Lobectomy For Early Stage Lung Cancer

EP02.03-006. Oncological Outcome And Surgical Instruments in VATS Lobectomy For Early Stage Lung Cancer

Pdf Summary

This study aimed to examine the impact of different surgical instruments used in video-assisted thoracic surgery (VATS) lobectomy for lung cancer on overall survival and recurrence-free survival. The researchers retrospectively reviewed 187 patients who underwent VATS lobectomy with lymphadenectomy for stage I or II lung cancer. The patients were divided into two groups based on the type of instruments used for tissue dissection: the "energy device" group and the standard electrocoagulation group. The mean follow-up time was 34.1 months.<br /><br />The results showed that there were no statistically significant differences in overall survival and recurrence rate between the two groups. This suggests that the choice of surgical instrument does not appear to have an impact on long-term outcomes for patients undergoing VATS lobectomy for lung cancer.<br /><br />This study contributes to the growing body of evidence supporting the use of VATS for the surgical treatment of early-stage lung cancer. VATS is a less invasive alternative to open thoracotomy and has been shown to have comparable oncological outcomes. The findings of this study further highlight the safety and efficacy of VATS lobectomy in achieving adequate resection and lymphadenectomy for lung cancer.<br /><br />It is important to note that this study is retrospective and includes a relatively small sample size. Further research with larger cohorts and prospective study design is needed to confirm these findings. Nevertheless, this study provides valuable insights into the impact of surgical instruments on the outcomes of VATS lobectomy for lung cancer.

Asset Subtitle

Federico Femia

Meta Tag

Speaker Federico Femia

Topic Early Stage Non-small Cell Lung Cancer - Surgery

Keywords

surgical instruments

VATS lobectomy

lung cancer

overall survival

recurrence-free survival

energy device

standard electrocoagulation

follow-up time

oncological outcomes

retrospective study